Voloridge Investment Management
ARIA

Voloridge Investment Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Voloridge Investment Management’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-601,463
Closed -$7.48M – 795
2016
Q4 		$7.48M Sell
601,463
-396,677
-40% -$4.78M 0.16% 161
2016
Q3 		$13.7M Buy
+998,140
New +$10M 0.3% 52

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

Voloridge Investment Management's ARIA Position: Q1 2017 in Review

Voloridge Investment Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 601,463 shares — an estimated $7.48M sold.

Voloridge Investment Management first reported a position in ARIA in Q3 2016 and held it in 2 quarters. The position peaked at $13.7M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Voloridge Investment Management reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Voloridge Investment Management sold 601,463 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $7.48M.
  • Voloridge Investment Management first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 2 quarters.
  • Voloridge Investment Management's Ariad Pharmaceuticals Inc position peaked at $13.7M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Voloridge Investment Management's 13F filing for Q1 2017, filed 15 May 2017.